AVTX Executive Compensation
* In USD (Original Currency)
Filing Date (SEC Report) |
Year | Reporting Name | Salary | Bonus | Stock Award | Incentive Plan Compensation | Other Compensation | Total |
---|---|---|---|---|---|---|---|---|
2023-10-19 | 2022 | Garry Neil, M.D. Chief Executive Officer, President, Chairman of the Board and principal executive officer | 468,900 | 0 | 0 | 133,000 | 0 | 1,332,828 |
2023-10-19 | 2022 | Stephen Smolinski Former Chief Commercial Officer | 74,242 | 0 | 0 | 11,573 | 415,117 | 990,879 |
2023-10-19 | 2021 | Michael Cola Former Chief Executive Officer and former principal executive officer | 35,568 | 0 | 0 | 325,500 | 0 | 2,693,811 |
2023-10-19 | 2022 | Michael Cola Former Chief Executive Officer and former principal executive officer | 62,500 | 0 | 0 | 17,260 | 865,657 | 945,417 |
2023-10-19 | 2021 | Christopher Sullivan Chief Financial Officer and principal financial officer | 300,000 | 0 | 0 | 85,860 | 0 | 627,642 |
2023-10-19 | 2022 | Christopher Sullivan Chief Financial Officer and principal financial officer | 344,135 | 0 | 0 | 72,800 | 50,000 | 768,549 |
2023-10-19 | 2021 | Garry Neil, M.D. Chief Executive Officer, President, Chairman of the Board and principal executive officer | 423,000 | 0 | 0 | 239,587 | 0 | 1,234,071 |
2023-10-19 | 2021 | Stephen Smolinski Former Chief Commercial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
2022-04-25 | 2020 | Michael Cola Former Chief Executive Officer and former principal executive officer | 79,228 | 0 | 0 | 378,000 | 0 | 3,820,306 |
2022-04-25 | 2021 | Schond Greenway Former Chief Financial Officer and former principal financial officer | 293,269 | 0 | 0 | 141,708 | 0 | 1,676,585 |
2022-04-25 | 2020 | Schond Greenway Former Chief Financial Officer and former principal financial officer | 0 | 0 | 0 | 0 | 0 | 0 |
2022-04-25 | 2021 | H. Jeffrey Wilkins, M.D. Former Chief Medical Officer | 425,000 | 0 | 0 | 165,580 | 0 | 1,249,985 |
2022-04-25 | 2020 | H. Jeffrey Wilkins, M.D. Former Chief Medical Officer | 335,534 | 0 | 0 | 178,000 | 0 | 1,487,778 |
2022-04-25 | 2021 | Michael Cola Former Chief Executive Officer and former principal executive officer | 35,568 | 0 | 0 | 325,500 | 0 | 2,693,811 |
2021-04-27 | 2020 | H. Jeffrey Wilkins, M.D. Chief Medical Officer | 335,534 | 178,000 | 0 | 0 | 0 | 1,487,778 |
2021-04-27 | 2020 | Joseph Miller Former Chief Financial Officer, former principal financial officer, and former principal executive officer | 116,748 | 0 | 0 | 0 | 115,521 | 232,269 |
2021-04-27 | 2020 | Michael Cola Chief Executive Officer and principal executive officer | 79,228 | 378,000 | 0 | 0 | 0 | 3,820,306 |
2021-04-27 | 2019 | Michael Cola Chief Executive Officer and principal executive officer | 0 | 0 | 0 | 0 | 0 | 0 |
2021-04-27 | 2019 | Joseph Miller Former Chief Financial Officer, former principal financial officer, and former principal executive officer | 356,000 | 222,000 | 0 | 0 | 0 | 1,170,598 |
2021-04-27 | 2020 | Garry Neil, M.D. Chief Scientific Officer | 372,932 | 296,000 | 0 | 0 | 0 | 2,688,804 |
2021-04-27 | 2019 | Garry Neil, M.D. Chief Scientific Officer | 0 | 0 | 0 | 0 | 0 | 0 |
2021-04-27 | 2019 | H. Jeffrey Wilkins, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
2020-04-28 | 2019 | Joseph Miller Former Chief Financial Officer, former Principal Financial Officer, and former Principal Executive Officer | 356,000 | 222,000 | 0 | 0 | 0 | 1,170,598 |
2020-04-28 | 2018 | Joseph Miller Former Chief Financial Officer, former Principal Financial Officer, and former Principal Executive Officer | 153,600 | 61,370 | 202,500 | 0 | 0 | 672,985 |
2020-04-28 | 2019 | Peter Greenleaf Former Chief Executive Officer and former Principal Executive Officer | 175,750 | 0 | 0 | 0 | 559,454 | 735,204 |
2020-04-28 | 2018 | Peter Greenleaf Former Chief Executive Officer and former Principal Executive Officer | 456,000 | 360,000 | 1,696,000 | 0 | 10,000 | 5,090,787 |
2020-04-28 | 2019 | Simon Pedder, Ph.D. Former Executive Chairman of the Board | 247,917 | 157,500 | 1,245,000 | 0 | 270,267 | 3,776,649 |
2020-04-28 | 2018 | Simon Pedder, Ph.D. Former Executive Chairman of the Board | 0 | 0 | 0 | 0 | 27,644 | 27,644 |
2020-04-28 | 2019 | Pericles Calias, Ph.D. Former Chief Scientific Officer | 324,167 | 140,000 | 224,100 | 0 | 0 | 1,345,362 |
2020-04-28 | 2018 | Pericles Calias, Ph.D. Former Chief Scientific Officer | 119,167 | 47,868 | 0 | 0 | 0 | 351,305 |
2019-06-19 | 2017 | Peter Greenleaf Former Chief Executive Officer | 0 | 0 | 0 | 0 | 29,136 | 29,136 |
2019-06-19 | 2018 | Peter Greenleaf Former Chief Executive Officer | 456,000 | 360,000 | 1,696,000 | 0 | 10,000 | 5,090,787 |
2019-06-19 | 2017 | Mariam E. Morris Former Chief Financial Officer | 295,200 | 78,750 | 16,798 | 0 | 6,718 | 397,466 |
2019-06-19 | 2018 | Mariam E. Morris Former Chief Financial Officer | 164,767 | 0 | 0 | 0 | 335,833 | 687,468 |
2019-06-19 | 2017 | Robert C. Moscato, Jr . Former President, Chief Operating Officer and Director | 25,000 | 0 | 0 | 0 | 0 | 25,000 |
2019-06-19 | 2018 | Robert C. Moscato, Jr . Former President, Chief Operating Officer and Director | 70,685 | 0 | 0 | 0 | 200,000 | 270,685 |
2019-06-19 | 2017 | James A. Harrell, Jr. Executive Vice President, Marketing and External Communications | 0 | 0 | 0 | 0 | 0 | 0 |
2019-06-19 | 2018 | James A. Harrell, Jr. Executive Vice President, Marketing and External Communications | 201,500 | 124,000 | 0 | 0 | 0 | 621,500 |
2019-06-19 | 2017 | Joseph M. Miller Chief Financial Officer, Principal Executive Officer and Principal Financial Officer | 0 | 0 | 0 | 0 | 0 | 0 |
2019-06-19 | 2018 | Joseph M. Miller Chief Financial Officer, Principal Executive Officer and Principal Financial Officer | 153,600 | 61,370 | 202,500 | 0 | 0 | 672,985 |
2018-04-05 | 2017 | Uli Hacksell, Ph.D. Former President and Chief Executive Officer | 439,577 | 0 | 0 | 0 | 46,350 | 553,119 |
2018-04-05 | 2016 | Uli Hacksell, Ph.D. Former President and Chief Executive Officer | 500,000 | 0 | 0 | 0 | 60,000 | 1,746,181 |
2018-04-05 | 2016 | Robert C. Moscato, Jr . Former President, Chief Operating Officer and Director | 0 | 0 | 0 | 0 | 0 | 0 |
2018-04-05 | 2016 | Mariam E. Morris Chief Financial Officer | 295,200 | 0 | 0 | 0 | 24,696 | 432,127 |
2018-04-05 | 2017 | Mariam E. Morris Chief Financial Officer | 295,200 | 0 | 0 | 0 | 6,718 | 318,716 |
2018-04-05 | 2017 | Robert C. Moscato, Jr . Former President, Chief Operating Officer and Director | 25,000 | 0 | 0 | 0 | 0 | 25,000 |
2018-04-05 | 2016 | John Kaiser Former Chief Business Officer and interim Chief Executive Officer | 297,000 | 0 | 0 | 0 | 0 | 450,411 |
2018-04-05 | 2017 | John Kaiser Former Chief Business Officer and interim Chief Executive Officer | 321,871 | 0 | 0 | 0 | 6,718 | 355,644 |
2018-04-05 | 2016 | Ronald Marcus, M.D. Former Chief Medical Officer | 356,200 | 0 | 0 | 0 | 24,000 | 581,125 |
2018-04-05 | 2017 | Ronald Marcus, M.D. Former Chief Medical Officer | 354,145 | 0 | 0 | 0 | 19,142 | 373,287 |
2017-03-31 | 2015 | Ronald Marcus, M.D. Chief Medical Officer | 213,375 | 63,459 | 0 | 0 | 19,000 | 504,447 |
2017-03-31 | 2016 | Ronald Marcus, M.D. Chief Medical Officer | 356,200 | 0 | 0 | 0 | 24,000 | 581,125 |
2017-03-31 | 2015 | Uli Hacksell, Ph.D. President and Chief Executive Officer | 0 | 0 | 0 | 0 | 0 | 69,365 |
2017-03-31 | 2016 | Uli Hacksell, Ph.D. President and Chief Executive Officer | 500,000 | 0 | 0 | 0 | 60,000 | 1,746,181 |
2017-03-31 | 2016 | John Kaiser Chief Business Officer | 297,000 | 0 | 0 | 0 | 0 | 450,411 |
2017-03-31 | 2015 | John Kaiser Chief Business Officer | 292,013 | 89,100 | 0 | 0 | 0 | 498,117 |
2016-04-08 | 2015 | John Kaiser Chief Business Officer | 292,013 | 89,100 | 0 | 0 | 0 | 498,117 |
2016-04-08 | 2015 | Ronald Marcus, M.D. Chief Medical Officer | 213,375 | 63,459 | 0 | 0 | 19,000 | 504,447 |
2016-04-08 | 2014 | Blake M. Paterson, M.D. Former President and Chief | 390,000 | 199,063 | 0 | 0 | 0 | 685,856 |
2016-04-08 | 2015 | Blake M. Paterson, M.D. Former President and Chief | 395,208 | 207,500 | 0 | 0 | 19,154 | 1,089,878 |
2016-04-08 | 2014 | John Kaiser Chief Business Officer | 290,700 | 116,494 | 0 | 0 | 0 | 452,932 |
2016-04-08 | 2014 | Ronald Marcus, M.D. Chief Medical Officer | 0 | 0 | 0 | 0 | 0 | 0 |
Disclaimer: The data contained in this website is not necessarily real-time nor accurate. All derived (stocks, indexes, futures) and Forex prices are not provided by exchanges but rather by our third party API www.financialmodellingprep.com, and so prices may not be accurate and may differ from the actual market price, meaning prices are indicative and not appropriate for trading purposes. Therefore, Discounting Cash Flows Inc. doesn't bear any responsibility for any trading losses you might incur as a result of using this data. Discounting Cash Flows Inc. or anyone involved with Discounting Cash Flows Inc. will not accept any liability for loss or damage as a result of reliance on the information including data, quotes, charts and buy/sell signals contained within this website. Please be fully informed regarding the risks and costs associated with trading the financial markets, it is one of the riskiest investment forms possible.